GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (LSE:BVXP) » Definitions » Common Stock

Bioventix (LSE:BVXP) Common Stock : £0.26 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bioventix Common Stock?

Bioventix's quarterly common stock stayed the same from Dec. 2023 (£0.26 Mil) to Jun. 2024 (£0.26 Mil) and stayed the same from Jun. 2024 (£0.26 Mil) to Dec. 2024 (£0.26 Mil).

Bioventix's annual common stock increased from Jun. 2022 (£0.26 Mil) to Jun. 2023 (£0.26 Mil) but then stayed the same from Jun. 2023 (£0.26 Mil) to Jun. 2024 (£0.26 Mil).


Bioventix Common Stock Historical Data

The historical data trend for Bioventix's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioventix Common Stock Chart

Bioventix Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.26 0.26 0.26 0.26

Bioventix Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.26 0.26 0.26 0.26

Bioventix Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Bioventix Business Description

Traded in Other Exchanges
Address
27–28 Eastcastle Street, London, GBR, W1W 8DH
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.

Bioventix Headlines

No Headlines